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Abstract

The epithelioid cell histiocytoma (ECH) is a polypoidal benign tumor of superficial connective tissue
that is often diagnosed as a pyogenic granuloma. ECHs are speculated to originate from dermal

dendritic subunits and are composed of 2 primary cell populations, ie, CD34+ primitive fibroblastic
dendrocytes and factor XIIIa+ histiocytes. Although dendritic subunits are distributed throughout most
collagenous tissues inclusive of oral mucosa, to date, all reported cases of ECH have been cutaneous
lesions. ECHs' putative pathogenesis entails activation of CD34+ “sentinel” reserve dendrocytes,
followed by an influx of histiocytes and mast cells. Juxtacrine communication increases release of
wound healing factors; suggesting a reactive etiologic component. In this current case, the location
(ventral tongue) and history (recent increase in size) suggest the possibility that trauma could have
initiated the dendritic subunit “wound healing” cascade. Consistent with its benign course, the ECH is
managed by local excision, and has an excellent prognosis.
The epithelioid cell histiocytoma was first described in 1989.1 It is a benign, exophytic connective tissue
neoplasm with a vascular appearance giving it the silhouette of a pyogenic granuloma. Several papers
have characterized its clinical and histopathological features.1, 2, 3, 4, 5, 6, 7, 8, 9, 10 To date, however, all
reported lesions presented as cutaneous tumors (Table I). We describe, for the first time, a case of an
epithelioid cell histiocytoma (ECH) arising on the mucous membrane of the ventral surface of the
tongue.

Table I. Demographic and clinical features of reported epithelioid cell histiocytomas
Reference
No. of
Male/Female Age
Site (skin)
Size,
cases
range, y
cm
Jones et al, 19891
19
8/11
24-63
Lower limb: 14
0.51.5

Mehregan et al,
19926

8

Estrada et al,
199211

2

Glusac et al, 1994

9

10

6/2

0/2
8/2

19-76

Lower limb: 5

12-46

Back: 1
Upper limb: 1
Nasolabial fold: 1
Lower limb: 1

19-72

Upper limb: 1
Lower limb: 9
Upper limb: 1

Gomez et al, 19943

20

12/8

7-80, NA
1 case

Lower limb: 6
Upper limb: 8
Abdomen: 2

Duration

Clinical diagnosis

Months-years

Pyogenic granuloma: 8

0.71.5

6 mo-2 y

Fibrous histiocytoma: 6
Melanotic lesion: 3
Glomus tumor: 1
Basal cell carcinoma: 1
Papilloma: 1
Eccrine poroma: 1
Intradermal nevus: 5

NA

NA

Angiofibroma: 1

NA
06.1.7

NA
3 mo-1 y (in
known cases)

Dermatofibroma: 1
Melanotic lesion: 3

0.52.0

5 mo-18 y (10
cases)

Fibroma: 3

Uncertain: 3
Pyogenic granuloma: 2
Adnexal tumor: 2
Angioma: 2
Fibroma: 1
Basal cell carcinoma: 1
Dermatofibroma: 1
NA: 11
Cyst: 2
Lipoma: 2
Pyogenic granuloma: 1

Eyelid and canthus:
2

Dezfoulian et al,
19954

2

Wilk et al, 1996

7

12

Manente et al,
19978
Zelger et al, 199710
Glusac and McNiff,
19997

2/0
4/3

38-46

Anus margin: 1
NA: 1
Lower limb: 1

28-56

Neck: 1
Lower limb: 5

1

1/0

13

Upper limb: 2
Groin: 1

1
15

0/1
10/5

34
23-65

Upper limb: 1
Lower limb: 8
Upper limb: 4
Face: 2

Fibroma: 1

0.8,
NA

3 mo, NA

Nevus: 1
Hemangioma: 1
Keratoacanthoma: 1
NA, NA

0.61.1

NA

NA

0.6

3 mo

Epithelioid histiocytoma

0.7
0.31.4

< 9 mo
1 mo-15 y (9
cases)
NA: 4
Several years:
2

NA
Melanotic lesion: 5

Abdomen: 1

Cook and Theaker,
20015
Stewart et al,
200313
Our case
TOTAL

Squamous carcinoma: 3
Basal cell carcinoma: 2

1

1/0

34

Neck: 1

NA

NA

Dermatofibroma: 2
Uncertain: 2
Fibroma: 1
Pyogenic granuloma: 1
Keratoacanthoma: 1
Seborrheic keratosis: 1
NA

1

1/0

66

Lower limb: 1

1.5

Many years

NA

1
88

0/1
53/35 (1.5:1)

84
Average:
45.5

Ventral tongue: 1
Lower limb: 50

1.0
0.32.0

NA

Pyogenic granuloma: 1

Upper limb: 18

NA, Not available.

Abdomen: 3
Neck: 2
Back: 1
Groin: 1

Clinical presentation

An 84-year-old white woman presented with a nodule on the left ventral surface of her tongue of
unknown duration that appeared to suddenly increase in size over the previous month. The 1.0 × 0.7
cm asymptomatic lesion was exophytic and polypoidal with a granular surface that was red to focally
white in color. The lesion was firm and nontender on palpation. The clinical impression was of a
pyogenic granuloma. A simple uneventful excisional biopsy was conducted and the tissue specimen
was submitted in 10% neutral buffered formalin for routine processing and histopathological
examination.

Microscopic and immunohistochemical features

Hematoxylin and eosin–stained sections demonstrated the exophytic nature of the tumor. Lesional
tissue was enclosed by collarettes of surface epithelium that were contiguous with a focally ulcerated
surface epithelium (Fig 1). Granulation tissue covered lesional cells in areas of ulceration. In other
areas, the lesional cells were distributed in the papillary lamina propria (Fig 2). The lesional cell
distribution appeared homogeneous and did not extend into the deeper connective tissues. The
lesional cells displayed both an epithelioid and a spindled morphology. Mast cells were frequently
observed in close proximity to the epithelioid cells. Lush vascularity as well as scattered, normalappearing mitotic figures were apparent (Fig 3). As the overall features suggested a well-vascularized
benign epithelioid neoplasm, diagnostic considerations included a lobular capillary hemangioma,
epithelioid spitz nevus, and a benign histiocytic neoplasm.

Fig 1. The lesion projects above the surrounding mucosa. Collarettes of epithelium enclose lesional cells
(hematoxylin and eosin [H&E], ×10 image scale).

Fig 2. Epithelioid and spindle-shaped lesional cells closely approximate the surface epithelium (H&E,
×250 image scale).

Fig 3. The lesional tissue composed of epithelioid to spindle-shaped cells with vesicular nuclei and small
nucleoli. Scattered inflammatory cells and normal appearing mitotic figures are also seen (H&E, ×400
image scale).
A battery of immunohistochemical stains were then conducted to provide a definitive diagnosis (Table
II). Standard positive (known positive tissue) and negative (positive tissue without antibody) controls
were conducted with each immunohistochemical stain. The immunohistochemical staining profile of
this case is shown in Table III. Despite the epithelioid appearance of many of the lesional cells, only the
surface epithelium demonstrated cytokeratin positivity. While CD31 and CD34 staining was prominent,
positivity was primarily demonstrated by endothelial cells associated with the extensive vascularity (Fig
4). Occasional mild to moderate CD34 positivity was observed in dermal dendritic cells. Alpha smooth
muscle actin as well as muscle-specific actin (HHF 35) highlighted the myopericytes surrounding the
tumor vasculature (Fig 5). Scant S100 positivity was noted within intraepithelial Langerhans cells as
well as scattered connective tissue dendritic cells (Fig 6). While the cytoplasm of the epithelioid
histiocytes stained weak to moderately with factor XIIIa, strong nuclear and cytoplasmic reactivity to
factor XIIIa was demonstrated within the S-100 negative dendritic histiocytes (Fig 7). CD117 positive
mast cells were noted in areas that strongly expressed factor XIIIa positive dendrocytes (Fig 8). Focal
CD68 positivity, consistent with infiltrating macrophages, was noted within the specimen. Stronger
CD68 reactivity was apparent at sites with a more extensive inflammatory infiltrate, ie, areas
underlying ulceration. Collectively, the light microscopic features, including abundant
neovascularization in a background of epithelioid and spindled cells in conjunction with the
immunohistochemical staining profile, were consistent with a diagnosis of an epithelioid cell
histiocytoma, a lesion hitherto undescribed in the oral cavity.
Table II. Immunohistochemical antibodies, retrieval techniques, dilutions, and antibody source
Antibody
Antigen retrieval (Target retrieval
Dilution Source/clone
solution, DAKO)
Cytokeratin
Yes
1:100
DAKO/AE1/AE3
CD31
Yes
1:80
DAKO/JC70A
CD34
Yes
1:500
IMMUNOTECH/QBEND10
Actin, α-smooth
No
1:500
DAKO/1A4
muscle
Actin, muscle
Yes
1:250
DAKO/HHF35
S100
Yes
1:4000 DAKO/POLYCLONAL

Factor XIIIa

Yes

1:60

CD68
CD117

Yes
Yes

1:3000
1:300

CELL
MARQUE/POLYCLONAL
DAKO/KP1
DAKO/POLYCLONAL

Table III. Immunohistochemical results of current case
Antibody
Result
CKC
Surface epithelium stained strongly. All other tissue stained negative.
CD31
Intense staining of vascular endothelium.
CD34
Positive staining of vascular endothelium.
Actin, α-smooth muscle Highlighted perivascular myopericytes.
Actin, muscle (HHF35)
Highlighted perivascular myopericytes.
S100
Less than 10% of cells in tumor stained positive. Dendritic morphology.
Also stained similarly dendritic cells within epithelium suggesting a
Langerhanian origin.
Factor XIIIa
Weak to moderate staining by epithelioid histiocytic cells. Strong nuclear
and cytoplasmic staining by dendritic histiocytes. Weak blush by matrix
collagen and intravascular fibrin.
CD68
Strong expression by macrophages in areas underlying ulceration and in
connective tissue septa.
CD117
Strongly expressed by mast cells.

Fig 4. A, CD31 and B, CD34 mark the endothelium of the numerous vascular channels within the tumor (×100
image scale).

Fig 5. Vascular myopericytes express α-smooth muscle actin (A) and muscle specific actin (HHF 35) (B) (×200
image scale).

Fig 6. Intraepithelial Langerhans cells and stromal dendritic cells strongly express S100 protein reactivity. The
S100 reactive cells comprised less than 10% of the lesional cells (×100 image scale).

Fig 7. Epithelioid histiocytes express weak to moderate cytoplasmic reactivity to factor XIIIa while strong nuclear
and cytoplasmic expression by stromal non-Langerhanian dendrocytes is noted (×200 image scale).

Fig 8. CD 117+ mast cell population among the lesional tissue (×100 image scale).

Management

The lesion was managed by surgical scalpel excision, and healing of the sutured wound was uneventful.
The patient is currently free of residual or recurrent disease.

Discussion

In 1989, Jones et al1 extended our understanding of fibrohistiocytic lesions by describing the
epithelioid cell histiocytoma, a neoplasm with a unique admixture of cells speculated to be derived
from the dermal microvascular unit.2 Although dermal dendritic subunits are distributed throughout

most collagenous tissues including the oral cavity,2, 14 to date there have been no reports of ECHs in the
oral cavity. Notably, the clinical presentation, light microscopic features, and immunohistochemical
staining profile of this current ventral tongue tumor compare favorably with the features previously
reported in cutaneous ECHs.1, 2, 3, 4, 5, 6, 7
Dermal dendritic subunits, which contain CD34+ fibroblasts and FXIIIa+ histiocytes serve as key players
in tissue remodeling and wound healing.2 The putative histogenesis of the ECH entails activation of a
subset of “sentinel” resident dermal (or submucosal) CD34+ primitive dendrocytes, which subsequently
act to recruit FXIIIa histiocytic dendrocytes and mast cells. Notably, the ECH lesional histiocytes
manifest a stromal assembly (FXIIIa) phenotype in contrast to a phagocytic (CD68+) phenotype. While
not categorized as lesional cells per se, mast cells contribute to ECH progression by release of potent
proangiogenic cytokines and tumor necrosis factor α, which subsequently increases expression of
transglutaminase XIIIa by dermal dendritic histiocytes.2 The end result is the juxtracrine mediated
activation of 2 dermal dendritic cell populations, ie, fibroblastic and histiocytic cells in conjunction with
abundant neovascularization. It has been suggested that CD34 expression by interstitial fibroblasts is
lost as they differentiate towards procollagen forming fibroblasts.2 The absence of CD34 expression by
lesional cells with a distribution proximate to the collagenous stroma suggests a similar transition in
this case.
The ECH presents as a solitary, exophytic, connective tissue nodule that ranges in size from 0.3-2.0 cm,
and varies in duration from 1 month7 to 18 years.3 Sites primarily affected are the skin over the lower
limbs followed by the upper extremities.1, 3, 6, 7, 9 Other cutaneous regions have included the neck4, 5;
back6; anus, eyelid, and canthus3; face6, 7; and abdomen.3, 7 The tumor has been diagnosed in almost all
decades of life (Table I) with the youngest patient being 7 years old3 and the oldest being 84 years old
(our case), which would average the age at 45.5 years. Although in their initial report of 19 cases, Jones
et al1 described a slight female predilection, an overall male-to-female ratio of 1.5:1 is noted (Table I).
Clinically, the epithelioid cell histiocytoma has a symmetrical outline and may be red, blue, or black in
color, depending on the degree of vascularity, extravasation of red cells, and formation of hemosiderin
pigment. Therefore, it may resemble a pyogenic granuloma or a nodular nevomelanocytic
proliferation. Upon microscopic examination, the epithelioid histiocytes and vague fascicles of spindle
cells are suggestive of other lesions including benign fibrous histiocytoma, epithelioid spitz nevus,
atypical xanthogranuloma, juvenile xanthogranuloma, reticulohistiocytoma, and epithelioid
hemangioma.1, 4, 6, 9
In contrast to melanocytic lesions, the ECH lacks junctional melanocytic hyperplasia, nesting of
nevocytes in theques, and downward maturation of epithelioid cells.3, 4, 13 Less than 10% S100 positive
cells are present in the ECH and their distribution is scattered to patchy.1, 4, 6, 7, 13, 15 Care should be used
in interpreting these S100 positive cells as they represent stromal dendritic cells rather than
nevomelanocytic cells. The nevocytes in melanocytic nevi are completely negative for factor XIIIa as
well as CD68.7, 15 As compared to the epithelioid cell histiocytoma, the epithelioid spitz nevi are less
well circumscribed with the epithelioid cells being separated by thick bundles of collagen.7, 9
Histopathologically, the pyogenic granuloma (lobular capillary hemangioma) may display a collarette of
epithelium surrounding lobules of angiomatous tissue. However, the CD31+/CD34+ capillaries16, 17 with

prominent protuberant endothelial cell nuclei in each angiomatous lobule appear to branch and
arborize from a central feeder vessel.7 The pyogenic granuloma, however, lacks the epithelioid cells
and factor XIIIa-positive dendrocytes are scarce.14, 18 In addition, inflammation is a much more
prominent feature in pyogenic granuloma.
The ECH is considered by some to be a variant of the benign fibrous histiocytoma (BFH).1, 2, 3, 6, 7
However, the BFH arises in a deeper location and is poorly circumscribed. It also demonstrates a
storiform pattern of arrangement of cells with thicker bundles of collagen. Lipid-laden and
hemosiderin-laden macrophages, giant cells, and inflammatory cells may also be seen in the BFH. In
contrast, the ECH contains a prominent epithelioid cell component admixed with numerous vascular
channels. Furthermore, due to its deeper origin, the BFH rarely demonstrates a polypoidal clinical
appearance.9, 13 While the BFH is categorized as a reactive fibrohistiocytic lesion, the ECH is considered
a benign dermal dendrocytic tumor. Due to its distinguishing microscopic features and probable
different histogenesis, it appears prudent to classify the ECH as a unique entity.
The reticulohistiocytoma differs from the epithelioid cell histiocytoma by demonstrating the presence
of inflammatory cells including eosinophils with variation in the morphology of the histiocytes and
multinucleate giant cells.1 The giant cells may be as large as 100 μm with a periodic acid Schiff stain
positive (PAS+) glassy eosinophilic cytoplasm. The nucleus is eccentrically located like a ganglion cell. A
prominent lymphocytic and conventional histiocytic (CD68+) infiltrate may also be seen.3, 7, 9, 13
The atypical fibroxanthomas have polypoidal architecture like the epithelioid cell histiocytoma.
Atypical fibroxanthomas, however, also demonstrate cellular pleomorphism, bizarre nuclear
morphology, and presence of numerous mitotic figures; features which are not observed in the ECH.1, 4,
7, 9

Juvenile xanthogranulomas are characterized by the presence of a prominent foam cell compartment,
Touton type, and other giant cells in addition to inflammatory cells and eosinophils.9 Like the
epithelioid cell histiocytoma, histiocytes within the juvenile xanthogranuloma may be positive for
factor XIIIa. In the event of FXIIIa positivity, concurrent expression of the macrophage antibody HAM56 by the juvenile xanthogranuloma cells facilitates diagnosis. Notably, HAM-56 is only expressed in 2%
to 5% of cells of the epithelioid cell histiocytoma.7, 9
The epithelioid hemangioma is another diagnostic consideration that must be differentiated from the
ECH.9 The epithelioid hemangioma also known as angiolymphoid hyperplasia with eosinophilia or
histiocytoid hemangioma typically shows a circumscribed symmetrical growth around a muscular
artery. The growth is characterized by a prominent proliferation of small, capillary-sized vessels lined
by plump, epithelioid endothelial cells. Lumen formation may be lacking. A moderate to severe
infiltration of lymphocytes and eosinophils accompanies this vascular proliferation.9, 10
The ECH is a unique but lesser-known vasoformative proliferation of epithelioid and dendritic
histiocytes. Diagnosis should be based on both clinical and microscopic features. Clinically, the lesion is
exophytic, pigmented, polypoidal, and may have a history of recent growth. Microscopically, the ECH
contains 3 primary cell populations, ie, epithelioid histiocytes, dermal dendrocytes, and mast cells,
which are contained in a richly vascularized connective tissue. In many respects, the ECH resembles a
variety of other reactive and neoplastic lesions from which it must be distinguished. Differential

diagnostic considerations for the ECH include the pyogenic granuloma, benign fibrous histiocytoma,
atypical and juvenile xanthogranulomas, nevomelanocytic lesions, and epithelioid hemangiomas. As
discussed previously, although the ECH is classified as a neoplasm, many lesional features, such as the
dermal dendritic subunit activation, imply a reactive process. Accordingly, conservative local excision is
curative, and the prognosis is excellent.
The authors wish to express their appreciation to Dr Brian Cutright, the Oral and Maxillofacial Surgeon
who contributed this case, and to our histotechnologist, Mary Lloyd.
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